(Q35561049)

8 August 2017

1 reference

title

Hyperprolactinemia and sexual function in men: a short review (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.IJIR.3901043

21 March 2024

author name string

J. Buvat

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14562140

21 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14562140

21 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://www.nature.com/articles/3901043.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.IJIR.3901043

https://www.nature.com/articles/3901043

21 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.IJIR.3901043

International Journal of Impotence Research

21 March 2024

published in

1 reference

8 August 2017

volume

15

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

373-377

1 reference

Absence of orgasm-induced prolactin secretion in a healthy multi-orgasmic male subject

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Hyperprolactinemia and sexual function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Tyrosine hydroxylase and POMC mRNA in the arcuate region are increased by castration and hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Experimental hyperprolactinemia in a rat model: alteration in centrally mediated neuroerectile mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Is routine endocrine testing of impotent men necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Hyperprolactinemia and impotence: why, when and how to investigate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Severe erectile dysfunction is a marker for hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Study of the effects of bromocriptine on sexual impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

Prolactinomas, testosterone-binding globulin, and androgen metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

The effects of bromocriptine on the sexual behaviour of hyperprolactinaemic man: a controlled case study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Normalization of Androgen and Sex Hormone-Binding Globulin Levels after Treatment of Hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Short-term endogenous hyperprolactinaemia and sexual behavior of male rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Routine endocrine screening in impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Routine prolactin measurement is not necessary in the initial evaluation of male impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Macroprolactinemia revisited: a study on 106 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Prolactin and testosterone: their role in male sexual function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

Is management of impotence with sildenafil changing clinical practice?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901043

7 January 2021

18

18

1167

J Buvat

1989

1 reference

https://api.crossref.org/works/10.1038/SJ.IJIR.3901043

21 March 2024

Identifiers

1 reference

8 August 2017

1 reference